Echocardiographic Right Ventricular Evaluation in Assessment of ARDS Lung Recruitment (ECHO-REVEAL)

NCT ID: NCT06812949

Last Updated: 2025-02-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

60 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-02-02

Study Completion Date

2026-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Study Goal The goal of this observational, multicenter study is to evaluate how positive end-expiratory pressure (PEEP) affects right ventricular (RV) function in patients with acute respiratory distress syndrome (ARDS) who are receiving mechanical ventilation. Researchers will assess the Recruitment-to-Inflation (R/I) ratio, a measurement used to determine whether increasing PEEP helps open the lungs or causes harmful effects on the heart and circulation.

Main Study Questions

This study aims to answer the following questions:

1. How does PEEP affect right heart function in ARDS patients?
2. Can the R/I ratio predict whether PEEP will have a beneficial or harmful impact on the heart?
3. Which echocardiographic parameters best detect changes in right ventricular function caused by PEEP?

Who Can Participate?

Patients will be included in the study if they meet the following criteria:

* Age: 18 to 80 years.
* Condition: Diagnosed with moderate-to-severe ARDS, with a PaO₂/FiO₂ ratio \<200 mmHg (an indicator of severe breathing difficulty).
* Mechanical Ventilation: Receiving invasive ventilation with at least 5 cmH₂O of PEEP and in deep sedation (fully dependent on the ventilator).
* Cardiac Monitoring: Equipped with a MostCare Up or equivalent device for continuous heart function monitoring.
* Informed Consent: Given directly by the patient or through a legal representative.

Patients will not be included in the study if they:

* Have severe pulmonary hypertension (high pressure in the lungs, ≥70 mmHg).
* Have a tricuspid valve prosthesis or other implanted cardiac devices that interfere with echocardiographic imaging.
* Have undergone recent heart surgery (within the past month).
* Have severe tricuspid valve disease that makes it difficult to assess right heart function.
* Are hemodynamically unstable, requiring high doses of medication to maintain blood pressure.
* Have poor ultrasound imaging conditions that prevent accurate heart scans.
* Have recently had a pulmonary embolism or have known blockages in the pulmonary arteries.
* Are receiving extracorporeal membrane oxygenation (ECMO) support.

Study Procedures

Participants will undergo a series of tests to measure the impact of PEEP on lung and heart function:

1. Initial Airway Closure Test: Patients will be evaluated while on a low PEEP level of 5 cmH₂O for 10 minutes to confirm eligibility.
2. Recruitment-to-Inflation (R/I) Ratio Assessment:

* PEEP will be adjusted between low (5 cmH₂O) and high (15 cmH₂O) levels.
* Researchers will measure changes in lung mechanics and heart function using ultrasound.
3. Echocardiographic Heart Function Assessment:

* Transthoracic echocardiography (TTE) will be performed at each PEEP level to assess the right ventricle (RV) and circulation in the lungs.
* Researchers will measure RV strain, size, and blood flow to determine how the heart reacts to PEEP changes.
4. Data Collection:

oKey respiratory and hemodynamic parameters will be recorded, including heart strain, cardiac output, pulmonary artery pressure, and venous congestion.

Primary and Secondary Study Outcomes

* Primary Outcome: The study will evaluate how RV function changes in response to different PEEP levels, using 2D RV strain measurements as a key indicator.
* Secondary Outcomes: Researchers will assess:

* How accurately echocardiographic measurements (e.g., TAPSE, FAC, VExUS score) detect changes in RV function.
* The relationship between the VExUS score (a marker of venous congestion) and RV strain changes.
* The sensitivity and specificity of echocardiographic findings in predicting heart function shifts under different PEEP levels.

Statistical Analysis

* Researchers will compare echocardiographic heart function results at high PEEP vs. low PEEP using statistical models.
* The relationship between the R/I ratio and RV function will be analyzed using correlation tests and logistic regression.
* Receiver Operating Characteristic (ROC) analysis will be used to determine which echocardiographic parameter best detects RV dysfunction when the R/I ratio is low.

Study Size and Impact The study aims to enroll 60 patients (30 per group) to ensure that results are reliable. This sample size was calculated to detect at least a 10% change in RV strain, with a 90% probability of identifying significant effects.

Expected Benefits of the Study This study will help critical care doctors better understand how to adjust PEEP settings to balance lung recruitment and heart function in ARDS patients. By identifying the best methods to detect right heart dysfunction early, this research could lead to improved ventilation strategies and better survival outcomes for patients with severe lung injury.m

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

ARDS

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

High Recruitment-to-Inflation (R/I) Ratio Group

This cohort includes ARDS patients with a Recruitment-to-Inflation (R/I) ratio \> 0.5, indicating high lung recruitability in response to increased PEEP. These participants undergo a structured PEEP titration protocol, where ventilatory and hemodynamic parameters are assessed at low PEEP (5 cmH₂O) and high PEEP (15 cmH₂O). The primary focus is on evaluating right ventricular function, pulmonary pressures, and systemic hemodynamics to determine if high recruitability is associated with better tolerance to PEEP without inducing RV dysfunction.

PEEP Titration with Echocardiographic, Hemodynamic, and Ventilatory Measurements

Intervention Type DIAGNOSTIC_TEST

This intervention consists of clinical recruitment maneuvers performed in mechanically ventilated patients by adjusting positive end-expiratory pressure (PEEP) at two levels: low PEEP (5 cmH₂O) and high PEEP (15 cmH₂O). Throughout these maneuvers, echocardiographic imaging, hemodynamic assessments, and ventilatory measurements are performed to evaluate the cardiorespiratory effects of PEEP adjustments. Transthoracic echocardiography (TTE) is used to assess right ventricular function, pulmonary pressures, and venous congestion, while mechanical ventilator parameters are recorded to monitor lung mechanics and compliance.

Low Recruitment-to-Inflation (R/I) Ratio Group

This cohort consists of ARDS patients with a Recruitment-to-Inflation (R/I) ratio \< 0.5, signifying limited lung recruitability and an increased risk of lung overdistension when PEEP is raised. These participants undergo the same PEEP titration protocol, with echocardiographic and ventilatory assessments at 5 cmH₂O and 15 cmH₂O PEEP levels. The objective is to evaluate the hemodynamic impact of higher PEEP in patients with poor lung recruitability, particularly in terms of right ventricular strain, pulmonary vascular resistance, and systemic venous congestion.

PEEP Titration with Echocardiographic, Hemodynamic, and Ventilatory Measurements

Intervention Type DIAGNOSTIC_TEST

This intervention consists of clinical recruitment maneuvers performed in mechanically ventilated patients by adjusting positive end-expiratory pressure (PEEP) at two levels: low PEEP (5 cmH₂O) and high PEEP (15 cmH₂O). Throughout these maneuvers, echocardiographic imaging, hemodynamic assessments, and ventilatory measurements are performed to evaluate the cardiorespiratory effects of PEEP adjustments. Transthoracic echocardiography (TTE) is used to assess right ventricular function, pulmonary pressures, and venous congestion, while mechanical ventilator parameters are recorded to monitor lung mechanics and compliance.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

PEEP Titration with Echocardiographic, Hemodynamic, and Ventilatory Measurements

This intervention consists of clinical recruitment maneuvers performed in mechanically ventilated patients by adjusting positive end-expiratory pressure (PEEP) at two levels: low PEEP (5 cmH₂O) and high PEEP (15 cmH₂O). Throughout these maneuvers, echocardiographic imaging, hemodynamic assessments, and ventilatory measurements are performed to evaluate the cardiorespiratory effects of PEEP adjustments. Transthoracic echocardiography (TTE) is used to assess right ventricular function, pulmonary pressures, and venous congestion, while mechanical ventilator parameters are recorded to monitor lung mechanics and compliance.

Intervention Type DIAGNOSTIC_TEST

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Recruitment Maneuvers with Cardiorespiratory Monitoring

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients within 1 week from the diagnosis of acute respiratory distress syndrome (ARDS), defined according to the Berlin criteria.
* Non-pregnant.
* Age greater than or equal to 18 years.
* Monitored through MostCare Up or any other system for cardiac output (CO) monitoring and with invasive CVP catheter.
* Able to provide written informed consent to participate in the study directly or by a delegate.

Exclusion Criteria

* Patients with severe pulmonary hypertension for any causes, defined by am echocardiographic PAPs ≥ 70 mmHg.
* Patients with tricuspid valve prostheses or percutaneous implanted devices (Triclip).
* Patients recently (within 1 month) undergoing cardiac surgery involving pericardiotomy.
* Patients with pre-existing severe tricuspid regurgitation.
* Patients with haemodynamic instability requiring high-dose vasopressors and/or inotropic agents in which recruitment manoeuvre are not considered to be safe according to clinical judgement.
* Patients whose acoustic window does not allow for the acquisition of the measurements under examination with transthoracic echocardiography.
* Patients with documented moderate-to-severe pulmonary embolism or known pulmonary artery stenosis.
* Patients undergoing Extracorporeal Membrane Oxygenation (ECMO).
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Erasme University Hospital

OTHER

Sponsor Role collaborator

Centre Hospitalier Universitaire Saint Pierre

OTHER

Sponsor Role collaborator

University of Bari

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Salvatore Grasso

Full Professor and Head of Intensive Care Department

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Francesco Grasso, Medicine and Surgery

Role: STUDY_CHAIR

University of Bari Aldo Moro

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hôpital universitaire - CHU Saint-Pierre

Brussels, Brussels Capital, Belgium

Site Status

Hôpital Erasme - Cliniques universitaires de Bruxelles

Brussels, Brussels Capital, Belgium

Site Status

Azienda Ospedaliero Universitaria Consorziale Policlinico

Bari, Bari, Italy

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Belgium Italy

References

Explore related publications, articles, or registry entries linked to this study.

Vieillard-Baron A, Schmitt JM, Augarde R, Fellahi JL, Prin S, Page B, Beauchet A, Jardin F. Acute cor pulmonale in acute respiratory distress syndrome submitted to protective ventilation: incidence, clinical implications, and prognosis. Crit Care Med. 2001 Aug;29(8):1551-5. doi: 10.1097/00003246-200108000-00009.

Reference Type BACKGROUND
PMID: 11505125 (View on PubMed)

Zapol WM, Snider MT. Pulmonary hypertension in severe acute respiratory failure. N Engl J Med. 1977 Mar 3;296(9):476-80. doi: 10.1056/NEJM197703032960903.

Reference Type BACKGROUND
PMID: 834225 (View on PubMed)

Vieillard-Baron A, Prin S, Chergui K, Dubourg O, Jardin F. Echo-Doppler demonstration of acute cor pulmonale at the bedside in the medical intensive care unit. Am J Respir Crit Care Med. 2002 Nov 15;166(10):1310-9. doi: 10.1164/rccm.200202-146CC. No abstract available.

Reference Type BACKGROUND
PMID: 12421740 (View on PubMed)

Banavasi H, Nguyen P, Osman H, Soubani AO. Management of ARDS - What Works and What Does Not. Am J Med Sci. 2021 Jul;362(1):13-23. doi: 10.1016/j.amjms.2020.12.019. Epub 2020 Dec 26.

Reference Type BACKGROUND
PMID: 34090669 (View on PubMed)

WHITTENBERGER JL, McGREGOR M, BERGLUND E, BORST HG. Influence of state of inflation of the lung on pulmonary vascular resistance. J Appl Physiol. 1960 Sep;15:878-82. doi: 10.1152/jappl.1960.15.5.878. No abstract available.

Reference Type BACKGROUND
PMID: 13784949 (View on PubMed)

Mahmood SS, Pinsky MR. Heart-lung interactions during mechanical ventilation: the basics. Ann Transl Med. 2018 Sep;6(18):349. doi: 10.21037/atm.2018.04.29.

Reference Type BACKGROUND
PMID: 30370276 (View on PubMed)

Price LC, McAuley DF, Marino PS, Finney SJ, Griffiths MJ, Wort SJ. Pathophysiology of pulmonary hypertension in acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2012 May 1;302(9):L803-15. doi: 10.1152/ajplung.00355.2011. Epub 2012 Jan 13.

Reference Type BACKGROUND
PMID: 22246001 (View on PubMed)

Evrard B, Goudelin M, Giraudeau B, Francois B, Vignon P. Right ventricular failure is strongly associated with mortality in patients with moderate-to-severe COVID-19-related ARDS and appears related to respiratory worsening. Intensive Care Med. 2022 Jun;48(6):765-767. doi: 10.1007/s00134-022-06730-0. Epub 2022 May 12. No abstract available.

Reference Type BACKGROUND
PMID: 35552780 (View on PubMed)

Repesse X, Charron C, Vieillard-Baron A. Acute cor pulmonale in ARDS: rationale for protecting the right ventricle. Chest. 2015 Jan;147(1):259-265. doi: 10.1378/chest.14-0877.

Reference Type BACKGROUND
PMID: 25560864 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Prot.2026/CEL

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.